🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Surgery As Needed for Oesophageal Cancer - 2

Recruitingn/aAges 18 Years - anyAllBas P. L. Wijnhoven
NCT04886635 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

A prospective cohort study on active surveillance after neoadjuvant chemoradiation for oesophageal cancer: SANO-2 study.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Operable patients who are planned to undergo or who recently underwent neoadjuvant chemoradiotherapy according to CROSS followed by surgical resection for histologically proven oesophageal squamous cell carcinoma or adenocarcinoma of the oesophagus or oesophago-gastric junction * Age ≥18 * Written, voluntary, informed consent. Exclusion Criteria: * Non-FDG-avid tumour at baseline PET-CT scan * Initial treatment with endoscopic resection * Patients who underwent of who are planned to undergo definitive chemoradiotherapy * Language difficulty, dementia or altered mental status prohibiting the understanding and giving of informed consent.
💊

What it tests

  • Active surveillance
📍

Where

1 site
Erasmus University Medical Center
Rotterdam, Netherlands
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy